PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Biotechnology
- Vol. 298, 88-97
Abstract
No abstract availableKeywords
Funding Information
- Center of Excellence of Research Council of the University of Isfahan
This publication has 47 references indexed in Scilit:
- General and Biomimetic Approach to Biopolymer-Functionalized Graphene Oxide Nanosheet through Adhesive DopamineBiomacromolecules, 2012
- Effect of surface modification of graphene oxide on photochemical stability of poly(vinyl alcohol)/graphene oxide compositesJournal of Industrial and Engineering Chemistry, 2012
- Cytotoxicity of Graphene Oxide and Graphene in Human Erythrocytes and Skin FibroblastsACS Applied Materials & Interfaces, 2011
- Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivityJournal of Materials Chemistry, 2010
- Influence of Reduced Folate Carrier and Dihydrofolate Reductase Genes on Methotrexate-Induced CytotoxicityCancer Research and Treatment, 2010
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Methotrexate γ-hydroxamate derivatives as potential dual target antitumor drugsBioorganic & Medicinal Chemistry, 2007
- Graphene-based composite materialsNature, 2006
- Methotrexate‐Immobilized Poly(ethylene glycol) Magnetic Nanoparticles for MR Imaging and Drug DeliverySmall, 2006
- Pharmacokinetics and Pharmacodynamics of Methotrexate in Non-Neoplastic DiseasesClinical Pharmacokinetics, 2003